{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:23:04Z","timestamp":1787242984003,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.lungcan.2015.09.012","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T12:47:35Z","timestamp":1442321255000},"page":"249-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer"],"prefix":"10.1016","volume":"90","author":[{"given":"Wouter W.","family":"Mellema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-9210","authenticated-orcid":false,"given":"Lucie","family":"Masen-Poos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbert F.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizza E.L.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim G.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arien","family":"Termeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn J.","family":"Goosens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.M.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel M.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7175-0026","authenticated-orcid":false,"given":"Anthonie J.","family":"van der Wekken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerarda J.M.","family":"Herder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1734-0696","authenticated-orcid":false,"given":"Frans H.","family":"Krouwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos A.","family":"Stigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben E.E.M.","family":"van den Borne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjeerd J.","family":"Haitjema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes J.","family":"Staal-Van den Brekel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert C.","family":"van Heemst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Pouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie C.","family":"Dingemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"February (5)","key":"10.1016\/j.lungcan.2015.09.012_bib0005","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1200\/JCO.2009.24.3030","article-title":"Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial","volume":"28","author":"Douillard","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"25","key":"10.1016\/j.lungcan.2015.09.012_bib0010","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1214886","article-title":"Crizotinib versus chemotherapy in advanced ALK-positive lung cancer","volume":"368","author":"Shaw","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"June (6)","key":"10.1016\/j.lungcan.2015.09.012_bib0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.6004\/jnccn.2013.0084","article-title":"Non-small cell lung cancer, version 2","volume":"11","author":"Ettinger","year":"2013","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"December (24)","key":"10.1016\/j.lungcan.2015.09.012_bib0020","doi-asserted-by":"crossref","first-page":"8919","DOI":"10.1158\/0008-5472.CAN-04-2818","article-title":"Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications","volume":"64","author":"Kosaka","year":"2004","journal-title":"Cancer Res."},{"issue":"October (20)","key":"10.1016\/j.lungcan.2015.09.012_bib0025","first-page":"5738","article-title":"Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung","volume":"48","author":"Rodenhuis","year":"1988","journal-title":"Cancer Res."},{"issue":"August (9)","key":"10.1016\/j.lungcan.2015.09.012_bib0030","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1056\/NEJM199008303230902","article-title":"K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung","volume":"323","author":"Slebos","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"January (1)","key":"10.1016\/j.lungcan.2015.09.012_bib0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1200\/JCO.1997.15.1.285","article-title":"Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study","volume":"15","author":"Rodenhuis","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"September (25)","key":"10.1016\/j.lungcan.2015.09.012_bib0040","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1200\/JCO.2005.02.857","article-title":"Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib","volume":"23","author":"Eberhard","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"July (1)","key":"10.1016\/j.lungcan.2015.09.012_bib0045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.lungcan.2009.09.010","article-title":"Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status","volume":"69","author":"Kalikaki","year":"2010","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"issue":"September (9)","key":"10.1016\/j.lungcan.2015.09.012_bib0050","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1097\/JTO.0b013e318298764e","article-title":"KRAS mutations in advanced nonsquamous non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy have no predictive value","volume":"8","author":"Mellema","year":"2013","journal-title":"J. Thorac. Oncol."},{"issue":"January (1)","key":"10.1016\/j.lungcan.2015.09.012_bib0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/annonc\/mdq680","article-title":"Different types of K-Ras mutations could affect drug sensitivity and tumour behaviour in non-small-cell lung cancer","volume":"22","author":"Garassino","year":"2011","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2015.09.012_bib0060","doi-asserted-by":"crossref","first-page":"e64816","DOI":"10.1371\/journal.pone.0064816","article-title":"Prognostic and predictive value of KRAS mutations in advanced non-small cell lung cancer","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS One"},{"issue":"January (3)","key":"10.1016\/j.lungcan.2015.09.012_bib0065","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.onc.1207188","article-title":"Kinase pathway is required for entry into mitosis and cell survival","volume":"23","author":"Liu","year":"2004","journal-title":"Oncogene"},{"issue":"September\u2013October (5)","key":"10.1016\/j.lungcan.2015.09.012_bib0070","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.neo.7900180","article-title":"Active erk regulates microtubule stability in H-ras-transformed cells","volume":"5","author":"Harrison","year":"2001","journal-title":"Neoplasia (New York, NY)"},{"issue":"January (2)","key":"10.1016\/j.lungcan.2015.09.012_bib0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.onc.1204062","article-title":"Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53","volume":"20","author":"Bacus","year":"2001","journal-title":"Oncogene"},{"issue":"August (4)","key":"10.1016\/j.lungcan.2015.09.012_bib0080","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr. Rev."},{"issue":"February (5)","key":"10.1016\/j.lungcan.2015.09.012_bib0085","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"August (8)","key":"10.1016\/j.lungcan.2015.09.012_bib0090","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc2403","article-title":"VEGF-targeted therapy: mechanisms of anti-tumour activity","volume":"8","author":"Ellis","year":"2008","journal-title":"Nat. Rev."},{"issue":"March (3)","key":"10.1016\/j.lungcan.2015.09.012_bib0095","first-page":"501","article-title":"The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancers","volume":"16","author":"Konishi","year":"2000","journal-title":"Int. J. Oncol."},{"issue":"August (3)","key":"10.1016\/j.lungcan.2015.09.012_bib0100","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/1097-0142(20010801)92:3<488::AID-CNCR1347>3.0.CO;2-F","article-title":"The association of K-ras gene mutation and vascular endothelial growth factor gene expression in pancreatic carcinoma","volume":"92","author":"Ikeda","year":"2001","journal-title":"Cancer"},{"issue":"February (3)","key":"10.1016\/j.lungcan.2015.09.012_bib0105","first-page":"228","article-title":"Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome","volume":"104","author":"Ihle","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"issue":"January (1)","key":"10.1016\/j.lungcan.2015.09.012_bib0110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1470-2045(12)70489-8","article-title":"Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study","volume":"14","author":"Janne","year":"2013","journal-title":"Lancet"},{"issue":"November (7477)","key":"10.1016\/j.lungcan.2015.09.012_bib0115","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature12796","article-title":"K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions","volume":"503","author":"Ostrem","year":"2013","journal-title":"Nature"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215300568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215300568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T06:57:18Z","timestamp":1537340238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500215300568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0169500215300568"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.09.012","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}